Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/9971
Full metadata record
DC FieldValueLanguage
dc.contributor.authorТалипова, Нозима-
dc.date.accessioned2024-01-14T13:41:23Z-
dc.date.available2024-01-14T13:41:23Z-
dc.date.issued2023-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/9971-
dc.description.abstractDiabetes is one of the most common somatic diseases and it has social, economic and medical importance. Type II diabetes affects 6,28 % population of the world. Patients with diabetes have an increased risk of anxiety disorders. This study focused on the study of anxiety-depressive disorders in patients with type II diabetes.30 patients in TMA clininc, endocrinology department were studied. Age of patients were from 44 till 70 years old. Duration of illnes from 2 month till 14 years. Glucose in blood was 6-28 mmol/L. HADS was used to evaluate the anxiety and depression.Analysis of anxiety using HADS showed that 56,6% of patients (17 cases) have subclinical and clinical anxiety, 20% of patients have depression. According to the questionnaire, which was taken from patients, common factors causing anxiety and depression were the long duration of diabetes mellitus, the increase in complications and low medical awareness of the disease.en_US
dc.language.isoenen_US
dc.subjectdiabetes II type, anxiety, depression, anxyolitic therapy, HADS (Hospital Anxiety and Depression Scale).en_US
dc.titleAnxiety and depressiv disorders in patients with diabetes IIen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
19.pdf8.36 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.